Product Information
QC ENEMA READY TO USE TWIN PAK is a generic product labeled by Chain Drug Marketing Association, priced at $0.0067 per ML under NDC 83324029390. Its NADAC has been published 87 times since Feb 5, 2025.
QC ENEMA READY TO USE TWIN PAK
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORMStrength
7; 19 g/118mL; g/118mL
Manufacturer
Chain Drug Marketing AssociationNDC
83324029390
Classification
Generic
Dosage Form
ENEMA
Route
RECTAL
Effective Date
9/23/2026
Active Ingredients
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORMApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007On Market Since
6/1/2010
Price Statistics
The NADAC for QC ENEMA READY TO USE TWIN PAK has been published 87 times since Feb 5, 2025, and over the history we have for it it has declined 28.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0067 per ML |
|---|---|
| All-time high | $0.0093 (Feb 12, 2025) |
| All-time low | $0.0062 (Jul 22, 2026) |
| 52-week high | $0.0077 |
| 52-week low | $0.0062 |
| Median price | $0.0066 |
| Average price | $0.0072 |
| Largest weekly change | -8.2% (Oct 22, 2025) |
| Weeks tracked | 87 |
| Tracking since | Feb 5, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC ENEMA READY TO USE TWIN PAK?
The current National Average Drug Acquisition Cost (NADAC) for QC ENEMA READY TO USE TWIN PAK, manufactured by Chain Drug Marketing Association, is $0.0067 per ML (NDC 83324029390), effective Sep 30, 2026.
How has the price of QC ENEMA READY TO USE TWIN PAK changed over time?
Over the history we have for it, the NADAC for QC ENEMA READY TO USE TWIN PAK has declined 28.1%. It has been tracked across 87 weekly CMS publications since Feb 5, 2025.
What are the highest and lowest recorded NADAC prices for QC ENEMA READY TO USE TWIN PAK?
Since Feb 5, 2025, the NADAC for QC ENEMA READY TO USE TWIN PAK has ranged from a low of $0.0062 (Jul 22, 2026) to a high of $0.0093 (Feb 12, 2025), with a median of $0.0066 per ML.
Are there cheaper alternatives to QC ENEMA READY TO USE TWIN PAK?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as QC ENEMA READY TO USE TWIN PAK in a comparable dosage form, but none are currently priced below it.
Who manufactures QC ENEMA READY TO USE TWIN PAK?
QC ENEMA READY TO USE TWIN PAK (NDC 83324029390) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.